Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Park Ha Biological Technology Co EV-to-OCF?
Park Ha Biological Technology CoBYAH -1.79%20 EV-to-OCF is 11.99 as of Aug. 29, 2026, which is 21% below its 10-year median of 15.22. GuruFocus rates BYAH with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,990 Consumer Packaged Goods companies, Park Ha Biological Technology Co ranks worse than 63.02% on this metric.
The historical rank and industry rank for Park Ha Biological Technology Co's EV-to-OCF or its related term are showing as below:
BYAH'
s EV-to-OCF Range Over the Past 10 Years
Min: -39.54 Med: 15.22 Max: 1115.45
Current: 11.99
During the past 5 years, the highest EV-to-OCF of Park Ha Biological Technology Co was 1115.45. The lowest was -39.54. And the median was 15.22.
BYAH's EV-to-OCF is ranked worse than 63.02% of 1990
companies
in the Consumer Packaged Goods industry
Industry Median: 8.14
vs BYAH: 11.99
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Park Ha Biological Technology Co (NAS:BYAH) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Park Ha Biological Technology Co's PE Ratio (TTM) for today is calculated as:
Park Ha Biological Technology Co's share price for today is $2.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was $-38.560.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Park Ha Biological Technology Co EV-to-OCF Related Terms
Park Ha Biological Technology Co EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Park Ha Biological Technology Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Park Ha Biological Technology Co EV-to-OCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Park Ha Biological Technology Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Park Ha Biological Technology Co's EV-to-OCF falls into.
Park Ha Biological Technology Co's current Enterprise Value is $-3.28 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Ha Biological Technology Co (BYAH) has a EV-to-OCF of 11.99 as of Aug. 29, 2026. This is 21% below median its historical median of 15.22. According to the industry distribution chart, Park Ha Biological Technology Co ranks #1254 out of 1990 companies in the Consumer Packaged Goods industry, placing it in the top 63%.
Is Park Ha Biological Technology Co's EV-to-OCF too high?
Park Ha Biological Technology Co's current EV-to-OCF of 11.99 is 21% below median its 10-year median of 15.22. The Consumer Packaged Goods industry median EV-to-OCF is 8.14. Park Ha Biological Technology Co's value of 11.99 is 47.3% above this industry median. Based on the distribution chart, Park Ha Biological Technology Co ranks #1254 out of 1990 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Park Ha Biological Technology Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Ha Biological Technology Co's EV-to-OCF compare to CAWW and NASO?
According to the Consumer Packaged Goods industry distribution chart, Park Ha Biological Technology Co ranks #1254 out of 1990 companies for EV-to-OCF. This places Park Ha Biological Technology Co in the lower half of its industry. The industry median EV-to-OCF is 8.14. Park Ha Biological Technology Co's value of 11.99 is 47.3% above this benchmark. While the company's 10-year median is 15.22 vs. the industry median of 8.14, Park Ha Biological Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Consumer Packaged Goods company?
The median EV-to-OCF among Consumer Packaged Goods companies is 8.14, based on 1,990 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Park Ha Biological Technology Co's current EV-to-OCF of 11.99 is 47.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median EV-to-OCF is 8.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Park Ha Biological Technology Co's current EV-to-OCF is 11.99, which is 21% below median its own 10-year median of 15.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Ha Biological Technology Co stock overvalued right now?
Park Ha Biological Technology Co (BYAH) has a current EV-to-OCF of 11.99. The current EV-to-OCF is 11.99, which is 21% below median its 10-year median of 15.22 and 47.3% above the Consumer Packaged Goods industry median of 8.14. Park Ha Biological Technology Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Park Ha Biological Technology Co (BYAH), the current EV-to-OCF is 11.99 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
20GF Score
Get the complete analysis for BYAH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BYAH has been successfully added to your 
